Glickman Mark A

Avg. Two Year Performance

(87%) Avg. Purchase Return
(37%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(7%)27%33%(61%)(87%)
Purchase Success Rate0 of 11 of 11 of 10 of 10 of 1
Average Sale Return(5%)< 1%0%0%0%
Sale Success Rate1 of 21 of 20 of 20 of 20 of 2
Drugs » Drug Manufacturers - Other

Chief Commercial Officer:

Holdings: 29.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Commercial Officer:

Holdings: 25.93K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Commercial Officer:

Holdings: 250.19K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Major

SVP, Sales & Marketing:

Holdings: 36.16K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Related Products

EVP - Sales and Marketing:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--